A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy, Tolerability, and Safety Study of DFN-15 in Episodic Migraine With or Without Aura
Latest Information Update: 14 Sep 2023
At a glance
- Drugs Celecoxib (Primary)
- Indications Migraine; Migraine with aura; Migraine without aura
- Focus Therapeutic Use
- Sponsors Dr Reddys Laboratories
- 12 Sep 2023 According to a Scilex Holding Media Release, post-hoc analysis data from this study was presented at the 2023 Annual Brain Week Conference from September 6-8, 2023 in Las Vegas, NV.
- 12 Sep 2023 Post-hoc analysis results presented in a Scilex Holding Media Release.
- 16 Jun 2023 According to Scilex media release, company announced that presenting data on ELYXYB™ (celecoxib oral solution) for acute treatment of migraine with or without aura in adults at the 65th Annual Scientific Meeting of American Headache Society (AHS) to be held on June 14-18, 2023 in Austin, Texas.